Drugs / Longeveron Mesenchymal Stem Cells (LMSCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02982915 | Nov 2016 → Sep 2021 | — | Longeveron Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Longeveron Mesenchymal Stem Cells (LMSCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02982915 ↗ |
| Route | Intravenous | “Intravenously delivered” NCT02982915 ↗ |